Ajanta Pharma informs about loss of share certificate

27 Sep 2023 Evaluate

Pursuant to Regulation 39(3) and other applicable regulations of SEBI Listing Regulations, Ajanta Pharma has informed that Registrar and Transfer Agent of Company, Link Intime India has received intimation for loss of share certificate and request for issuance of duplicate share certificate from the shareholder: Ram Ramesh Pradhan (Folio No: 0008060), further details are enclosed. As required under the SEBI Circular No. SEBI /HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th May, 2022, Registrar and Transfer Agent will issue ‘Letter of Confirmation’ in lieu of physical duplicate share certificate, after necessary due diligence.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2960.30 9.75 (0.33%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.